1.

Record Nr.

UNINA9910964617303321

Titolo

The National Academies' guidelines for human embryonic stem cell research : 2008 amendments / / Human Embryonic Stem Cell Research Advisory Committee, Board on Life Sciences, Division on Earth and Life Studies, Board on Health Sciences Policy, Institute of Medicine, National Research Council and Institute of Medicine of the National Academies

Pubbl/distr/stampa

Washington, : National Academies Press, c2008

ISBN

9786611972943

9780309185677

030918567X

9781281972941

1281972940

9780309122214

030912221X

Edizione

[1st ed.]

Descrizione fisica

x, 54 p

Disciplina

616/.02774

Soggetti

Embryonic stem cells - Research

Human embryo - Research

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Bibliographic Level Mode of Issuance: Monograph

Nota di bibliografia

Includes bibliographical references (p. 20).

Nota di contenuto

Introduction -- Applicability of the guidelines to non-embryonic human pluripotent stem cells -- Clarification of the meaning of "proper notification" -- 1.3(a) hES cell research permissible after currently mandated reviews -- Public openness and ESCRO committee audits -- 2.0 Establishment of an institutional embryonic stem cell research oversight committee -- Clarification of policy regarding reimbursement for oocyte donors -- National Academies' guidelines for human embryonic stem cell research, amended as of September 2008.

Sommario/riassunto

In 2005, the National Academies released the report Guidelines for Human Embryonic Stem Cell Research, which offered a common set of ethical standards for a field that, due to the absence of comprehensive federal funding, was lacking national standards for research. In order to keep the Guidelines up to date, given the rapid pace of scientific



developments in the field of stem cell research, the Human Embryonic Stem Cell Research Advisory Committee was established in 2006 with support from The Ellison Medical Foundation, The Greenwall Foundation, and the Howard Hughes Medical Institute. As it did in 2007, the Committee identified issues that warranted revision, and this book addresses those issues in a second set of amendments. Most importantly, this book addresses new scientific developments in reprogramming of somatic cells to pluripotency by adding a new section and revising other relevant sections of the Guidelines.